Pfizer becomes first pharma company in India to seek...

New Delhi [India], December 6 (ANI): Pfizer India has become the first pharmaceutical firm to approach the Drugs...

DCGI gives nod for phase 3 trial of Bharat Biotech's COVID-19...

New Delhi [India], October 23 (ANI): In a major development, Drugs Controller General of India (DCGI) on Friday gave...

Russian Sputnik V COVID-19 vaccine to be tested on 100 Indian...

Moscow [Russia], October 23 (ANI): The Russian Sputnik V vaccine against COVID-19 will be tested in India on 100...

DCGI's expert panel recommends Phase 3 clinical trial nod for...

New Delhi [India], October 22 (ANI): The expert panel at Central Drugs Standard Control Organisation (CDSCO) has...

Expert panel recommends DCGI to permit Dr Reddy's Lab to...

New Delhi [India], October 17 (ANI): The expert committee of Drugs Controller General of India (DCGI) on Friday...

Dr Reddy's Lab submits revised protocol to DCGI to conduct...

New Delhi [India], October 13 (ANI): Indian drug maker Dr Reddy's Laboratories (DRL) has submitted a revised...

DCGI directs Dr Reddy's lab to furnish fresh protocol to seek...

New Delhi [India], October 6 (ANI): In the latest development, the Drugs Controller General of India (DCGI) expert...

Dr Reddy's Laboratories seeks DCGI permission to conduct...

New Delhi [India], October 2 (ANI): Indian pharma giant Dr Reddy's Laboratories (DRL) has submitted an...

DCGI issues guidelines for pharma giants manufacturing...

New Delhi [India], September 23 (ANI): The Drugs Controller General of India (DCGI) has issued a new set of...

First cost, time-effective CRISPER test for Covid-19 gets nod...

New Delhi [India], September 20 (ANI): The Drugs Controller General of India (DCGI) has given approval to the Tata...

DCGI approves India's first CRISPR Covid-19 test developed by...

New Delhi [India], September 19 (ANI): The Drug Controller General of India (DCGI), on Saturday gave approval for...

DCGI gives nod to Serum Institute to restart phase 2,3 trials...

New Delhi [India], September 16 (ANI): The Drugs Controller General of India (DCGI) has allowed Serum Institute of...